Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Item
http://www.wikidata.org/entity/Q33334362
Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.Immunotherapy in acute leukemiaOrchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge.Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.Activated mouse CD4(+)Foxp3(-) T cells facilitate melanoma metastasis via Qa-1-dependent suppression of NK-cell cytotoxicity.Natural killer cells in immunodefense against infective agents.The role of natural killer cells in hematopoietic stem cell transplantation.Novel antibody-based proteins for cancer immunotherapy.Hunting for clinical translation with innate-like immune cells and their receptors.Transient overexpression of Pparγ2 and C/ebpα in mesenchymal stem cells induces brown adipose tissue formation.In vitro modulation of natural killer activity of human peripheral blood mononuclear cells against prostate tumor cell line.Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.
P2860

Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.

Item
http://www.wikidata.org/entity/Q33334362
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@ast
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@en
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@nl
type
label
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@ast
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@en
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@nl
prefLabel
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@ast
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@en
Harnessing soluble NK cell kil ...... f novel cancer immune therapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Harnessing soluble NK cell kil ...... of novel cancer immune therapy
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0002150
P407
P433
P478
P50
P577
P5875
P698
P932